← Back to all stacks

Weight Loss & Metabolic Reset Stack

Category
Weight Loss & Metabolism
Purpose
Significant Fat Loss & Metabolic Improvement

Overview

A medically grounded weight loss stack anchored by FDA-approved semaglutide and enhanced by MOTS-c's peripheral insulin sensitization and BPC-157's GI protection and gut-brain axis modulation. Targets both the central appetite-regulation failure and the peripheral metabolic dysfunction that characterize obesity.

An FDA-approved weight-loss medication is paired with two supporting peptides that target fat-burning and gut health from angles the main medication doesn't cover.

Compounds in this stack

Semaglutide FDA Approved

The FDA-approved GLP-1 behind Ozempic and Wegovy. Reduces appetite, blood sugar, and heart disease risk.

MOTS-c Research

A peptide made inside your own mitochondria that mimics the metabolic benefits of exercise — improving energy and blood sugar control.

BPC-157 Research

A widely studied 'healing peptide' derived from stomach protein. Popular for helping the body repair muscle, tendon, and gut tissue faster.

Preferred Peptide Vendors →

⚠️ This page describes a combination of compounds that are, with few exceptions, not approved by the FDA for any use. It records protocols described in research and community sources. It is not a recommendation, not a prescription, and not medical advice. Combining compounds multiplies the unknowns rather than adding them. Do not act on anything here without a qualified healthcare professional who knows your history.